Tomáš U.
- Country
- Slovakia
- Department
- 2701:Kožná ambulancia Youderm
Research Overview
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
- A Multicenter, Double-Blind, Randomized Withdrawal Study of Subcutaneous Secukinumab for Long-Term Efficacy and Safety in Moderate to Severe Hidradenitis Suppurativa
- Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 76 of 156 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating hidradenitis suppurativa, focusing particularly on moderate to severe manifestations of this chronic inflammatory skin condition.
- Chronic Inflammatory Disease Management
- Long-term Treatment Strategies
- Disease Response Assessment
Their research interests center on evaluating sustained therapeutic responses and exploring continuous versus interrupted treatment protocols in inflammatory dermatology.
Treatment Innovation
The investigator's work involves exploring novel approaches to treatment regimens and dosing strategies for chronic inflammatory conditions.
- Dosing Optimization
- Treatment Continuity Assessment
- Long-term Efficacy Evaluation
Their research examines the comparative effectiveness of different treatment intervals and maintenance protocols in dermatological conditions.
Clinical Response Evaluation
The investigator focuses on analyzing treatment responses in chronic inflammatory skin conditions, with particular attention to long-term outcomes.
- Response Duration Assessment
- Treatment Sustainability
- Clinical Outcome Measures
Their work emphasizes the evaluation of sustained clinical responses and the development of optimal therapeutic maintenance strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.